agile therapeutics c our company overview of agile management team board of directors key advisorsconsultants scientific advisory board product pipeline technology twirla ag other product candidates investor relations press releases events  presentations corporate governance financials  filings stock information investor faqs contact us contact us agile therapeutics is a forwardthinking womens healthcare company dedicated to fulfilling the unmet health needs of todays women our current product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill without committing to a longeracting method our lead product candidate twirla® ethinyl estradiol and levonorgestrel transdermal system also known as ag is a onceweekly prescription contraceptive patch that recently completed phase  trials twirla is based on our proprietary transdermal patch technology called skinfusion® which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability our shortterm goal is to establish a marketleading franchise in the united states hormonal contraceptive market which had total market sales of approximately  billion in  news and events legal    terms and conditions     sitemap     home    contact follow agilether agile therapeutics  contact us our company overview of agile management team board of directors key advisorsconsultants scientific advisory board product pipeline technology twirla ag other product candidates investor relations press releases events  presentations corporate governance financials  filings stock information investor faqs contact us contact us contact us agile therapeutics is located at  poor farm road princeton nj  for general and media inquires email infoagiletherapeuticscom for business development email bdagiletherapeuticscom if you are a patient who is currently enrolled in an agile clinical trial please contact your study doctor with any questions or concerns please do not use this email to report studyrelated issues legal    terms and conditions     sitemap     home    contact follow agilether press releases  agile therapeutics our company overview of agile management team board of directors key advisorsconsultants scientific advisory board product pipeline technology twirla ag other product candidates investor relations press releases events  presentations corporate governance financials  filings stock information investor faqs contact us contact us investor relations overview press releases events  presentations corporate governance management board of directors committee composition financials  filings sec filings stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools shareholder briefcase email alerts snapshot rss news feeds press releases   year all years         sort by date descending date ascending update   press releases date title and summary view jun   agile therapeutics resubmits new drug application nda for its transdermal contraceptive patch twirla® princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced it has resubmitted to the us food and drug administration fda the nda for its lead product candidate twirla® an investigational lowdose combined hormonal contraceptiv pdf add to briefcase file is in briefcase may   agile therapeutics reports first quarter  financial results princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today reported financial results for the three months ended march   and provided a corporate update for the first quarter  first quarter  and other recent corp pdf add to briefcase file is in briefcase may   agile therapeutics reports additional phase  secure study results relating to twirla® at acog  princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced the presentation of additional results of its phase  secure trial of its investigational lowdose combination hormone contraceptive patch twirla® ag anita nelson md profess pdf add to briefcase file is in briefcase may   agile therapeutics to present additional phase  data at the  annual clinical and scientific meeting of the american congress of obstetricians and gynecologists princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced that data from its phase  secure study will be presented at the interactive eposter session during the  annual clinical and scientific meeting of the american congress of obstetricians a pdf add to briefcase file is in briefcase apr   agile therapeutics announces presentation of secure phase  data at the  congress on womens health princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company announced today that a presentation entitled an update on hormonal contraception and the changing us population will be presented by coprincipal investigator of the secure clinical trial anit pdf add to briefcase file is in briefcase apr   agile therapeutics announces results of its presubmission meeting with fda princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced it has received the final meeting minutes from its recent new drug application nda presubmission meeting with the us food and drug administration fda for its lead product candidate  pdf add to briefcase file is in briefcase mar   agile therapeutics announces a poster presentation of its secure phase  study at the contraceptive technology  conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company announced a poster presentation of data from the secure phase  clinical trial for its lead product candidate twirla® ethinyl estradiol and levonorgestrel transdermal system also known pdf add to briefcase file is in briefcase mar   agile therapeutics reports fourth quarter and full year  financial results princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company today reported financial results for the three months and year ended december   and provided a corporate update for the fourth quarter   pdf add to briefcase file is in briefcase mar   agile therapeutics to present at th annual roth conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at th annual roth conference on monday march   at  pm pacific time the conference is being held  pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the rbc capital markets  global healthcare conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at the rbc capital markets  global healthcare conference on february   at  am et at the new york palace in new  pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  bio ceo  investor conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at the  bio ceo  investor conference on monday february   at  am et at the waldorf astoria in pdf add to briefcase file is in briefcase jan   agile therapeutics to present at noble capital markets thirteenth annual investorequity conference princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at noble capital markets thirteenth annual investor equity conference on tuesday january   at  am e pdf add to briefcase file is in briefcase jan   agile therapeutics announces positive topline phase  results resubmission of twirla® new drug application expected to address fdas complete response lettercompany plans to resubmit nda in first half of             company to host conference call on january   at  pm pdf add to briefcase file is in briefcase dec   agile therapeutics to present at biotech showcase  princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx announced today that its chief executive officer al altomari will present at the biotech showcase  on monday january   at  am pacific time   the conference will be held at the hilton san francisco union square pdf add to briefcase file is in briefcase dec   agile therapeutics to present at the th annual jp morgan healthcare conference princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at the th annual jp morgan healthcare conference on thursday january   at  am pacific time  pdf add to briefcase file is in briefcase dec   agile therapeutics receives approximately  million in nondilutive funding from new jerseys technology business tax certificate transfer program princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that it has received net proceeds of approximately  million in nondilutive financing through the state of new jerseys technology business tax certificate transfer pro pdf add to briefcase file is in briefcase nov   agile therapeutics reports third quarter  financial results and announces completion of subject visits for twirla® phase  secure clinical trial topline data expected in early january  resubmission planned for first half   cash expected to fund operations through the end of  princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a wom pdf add to briefcase file is in briefcase aug   agile therapeutics reports second quarter  financial results princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and six months ended june   and provide pdf add to briefcase file is in briefcase jul   agile therapeutics appoints seth h z fischer to its board of directors princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx today announced the appointment of seth h z fischer to the companys board of directors effective july    mr fischer will serve on agiles compensation and nominating  corporate governance committees  pdf add to briefcase file is in briefcase jul   agile therapeutics announces plans to advance contraceptive pipeline princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that preparations are underway for an initial phase  clinical trial of a novel  pdf add to briefcase file is in briefcase jul   agile therapeutics strengthens executive leadership team with new chief commercial officer princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that it had strengthened its executive leadership team with the appointment  pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the cantor fitzgeralds nd annual healthcare conference princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase jun   agile therapeutics announces issuance of patent for progestin patch designs princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued us patent  on june pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the william blair  companys th annual growth stock conference princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the jefferies  healthcare conference princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase may   agile therapeutics reports first quarter  financial results cash expected to fund operations through the end of clinical trial expected to complete in fourth quarter  and resubmission planned for first half  princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens heal pdf add to briefcase file is in briefcase apr   agile therapeutics to present at womens health  the th annual congress princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that dr elizabeth garner chief medical officer will present on the topic of subject recruitment f pdf add to briefcase file is in briefcase mar   agile therapeutics to present at the th annual needham healthcare conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase mar   agile therapeutics reports fourth quarter and full year  financial results princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three months and year ended december   and provided a corpor pdf add to briefcase file is in briefcase mar   agile therapeutics to present at the th annual roth conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the t pdf add to briefcase file is in briefcase feb   agile therapeutics appoints ajit s shetty phd to its board of directors princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx today announced that ajit s shetty phd has been appointed to the companys board of directors effective february    dr shetty will serve on agiles science  technology and nominating  governance committees  pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  rbc capital markets global healthcare conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the  pdf add to briefcase file is in briefcase feb   agile therapeutics inc announces full exercise of option to purchase additional shares by underwriters princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the underwriters of its previously announced public offering of common  pdf add to briefcase file is in briefcase jan   agile therapeutics announces pricing of its public offering of common stock princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced the pricing of its underwritten public offering of  shares of its c pdf add to briefcase file is in briefcase jan   agile therapeutics announces proposed offering of common stock princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that it intends to offer and sell  million of shares of its common stock sub pdf add to briefcase file is in briefcase jan   agile therapeutics to present at noble financial capital markets twelfth annual equity conference princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that katie macfarlane chief commercial officer will present at noble financial  pdf add to briefcase file is in briefcase dec   agile therapeutics receives approximately  million in nondilutive funding from new jerseys technology business tax certificate transfer program princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that it has received net proceeds of approximately  million in nondilutive financing through pdf add to briefcase file is in briefcase nov   agile therapeutics announces participation at upcoming investor conferences princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari president and chief executive officer will participate in  pdf add to briefcase file is in briefcase nov   agile therapeutics reports third quarter financial results princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and nine months ended september   and prov pdf add to briefcase file is in briefcase oct   agile therapeutics announces completion of patient enrollment in twirlar phase  secure clinical trial princeton nj oct   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that it has reached full enrollment in its ongoing phase  secure clinical tria pdf add to briefcase file is in briefcase sep   agile therapeutics to participate at fbr second annual healthcare conference princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari president and chief executive officer will participate at the fbr second annual h pdf add to briefcase file is in briefcase aug   agile therapeutics announces completion of patient recruitment in twirlar phase  secure clinical trial princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that active recruitment has closed in its ongoing singlearm openlabel phase  secure clinical tria pdf add to briefcase file is in briefcase aug   agile therapeutics announces presentation at upcoming conferences princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that management will present at the following conferences al altomari president and c pdf add to briefcase file is in briefcase aug   agile therapeutics reports second quarter financial results princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and six months ended june   and provided a corporate update fo pdf add to briefcase file is in briefcase jul   agile therapeutics announces allowance of several patents on novel dosing regimens for its pipeline of followon contraceptive products princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued notices of allowance between july  and  for fo pdf add to briefcase file is in briefcase jul   agile therapeutics to present at the cantor fitzgerald inaugural healthcare conference princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the cantor fitzgerald inaugura pdf add to briefcase file is in briefcase jun   agile therapeutics added to membership of russell r r and global indexes princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that its stock has been selected for addition to the us russell ® russell ® and  pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the jmp securities life sciences conference  princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the jmp securities life scien pdf add to briefcase file is in briefcase jun   agile therapeutics announces issuance of patent for twirlar patch design princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued us patent  on june   the newlyiss pdf add to briefcase file is in briefcase may   agile therapeutics to present at the william blair th annual growth stock conference princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the william blair th annual  pdf add to briefcase file is in briefcase may   agile therapeutics reports first quarter financial results princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the quarter ended march  first quarter  corporate developments inclu pdf add to briefcase file is in briefcase apr   agile therapeutics to present at the th annual needham healthcare conference princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the th annual needham healt pdf add to briefcase file is in briefcase mar   agile therapeutics reports fourth quarter and full year  financial results princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the fourth quarter and year ended december  fourth quarter  and ot pdf add to briefcase file is in briefcase mar   agile therapeutics to present at the th annual roth conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the th annual roth conferen pdf add to briefcase file is in briefcase feb   agile therapeutics secures debt facility from hercules technology growth capital of up to  million and provides update on status of clinical trial princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that it has entered into a loan and security agreement with hercules technology growth capital inc pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  rbc capital markets global healthcare conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the  rbc capital markets pdf add to briefcase file is in briefcase jan   agile therapeutics announces  million private placement and provides clinical trial update princeton new jersey jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that it has entered into a definitive stock purchase agreement with a group of institutional a pdf add to briefcase file is in briefcase jan   agile therapeutics to present at noble financial capital markets eleventh annual equity conference princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the noble financial capital ma pdf add to briefcase file is in briefcase dec   agile therapeutics to present at the rd annual jp morgan healthcare conference princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the rd annual jp morgan  pdf add to briefcase file is in briefcase dec   agile therapeutics announces publication of data on lowdose investigational contraceptive patch princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx today announced the publication of two manuscripts containing data from a phase  clinical trial of twirla® ag an investigational onceweekly contraceptive patch kaunitz a portman d westhoff c mishell d archer d foegh m new contracepti pdf add to briefcase file is in briefcase nov   agile therapeutics appoints john hubbard phd fcp to its board of directors princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx today announced that john hubbard phd fcp has been appointed to the companys board of directors effective november   dr hubbard will serve on agiles nominating and corporate governance committee johns exceptional pharmaceutical experien pdf add to briefcase file is in briefcase nov   agile therapeutics reports third quarter  financial results princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and nine months ended september   and provided a company upda pdf add to briefcase file is in briefcase oct   agile therapeutics appoints james p tursi md to its board of directors princeton nj oct   globe newswire  agile therapeutics inc nasdaqagrx announced today that james p tursi md has been appointed to the companys board of directors effective october   dr tursi will serve on the compensation committee james has significant clinical and regulatory expertise in the pharmaceutical i pdf add to briefcase file is in briefcase sep   agile announces dosing of first patients in twirlar phase  secure study princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the first patients have been dosed in its secure study the secure study is a singlearm open pdf add to briefcase file is in briefcase sep   agile to present at the st annual biocentury newsmakers conference princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari president and chief executive officer will present a business overview and updat pdf add to briefcase file is in briefcase sep   agile initiates phase  secure study for twirlatm twirla ag is a novel lowdose combined hormonal contraceptive patch designed using the companys proprietary transdermal skinfusion® technologyconfirmatory secure study to build upon data from previous phase  studies in support of the companys new drug application to the us food and drug administration princeton nj sept  pdf add to briefcase file is in briefcase sep   agile therapeutics to ring the nasdaq stock market closing bell princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that mr al altomari the companys president and chief executive officer will ring the nasdaq stock pdf add to briefcase file is in briefcase aug   agile therapeutics reports second quarter  financial results princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and six months ended june   and provided a company update on  pdf add to briefcase file is in briefcase jul   agile therapeutics announces allowance of additional patent claims for skinfusion® princeton nj july   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued a notice of allowance on july   for additional pdf add to briefcase file is in briefcase jun   agile therapeutics joins russell microcap® index princeton nj june   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced it has been added to the russell microcap index the company joined the index at the close of the mark pdf add to briefcase file is in briefcase jun   agile therapeutics announces issuance of new patent for its skinfusion® transdermal delivery device princeton nj june   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that patent us   patent was issued by the us patent and trademark office on june  pdf add to briefcase file is in briefcase jun   agile therapeutics to participate at the janney capital markets boston healthcare x corporate access day princeton nj june   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari the companys chief executive officer and president will participate at the janney  pdf add to briefcase file is in briefcase may   agile therapeutics announces pricing of initial public offering princeton nj may   prnewswire  agile therapeutics inc a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced the pricing of its initial public offering of  shares of its common stock at a public offering price of   pdf add to briefcase file is in briefcase mar   agile therapeutics files registration statement for proposed initial public offering pdf add to briefcase file is in briefcase feb   agile therapeutics announces appointment of science advisory board member pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  leerink global healthcare conference pdf add to briefcase file is in briefcase jan   agile therapeutics appoints dr elizabeth ijeoma onyemelukwe garner as chief medical officer pdf add to briefcase file is in briefcase oct   agile president and ceo appointed as an officer of the deans advisory board drexel university lebow college of business the dean’s advisory board elected five new members and three new officers at its fall meeting – its first held in gerri c lebow hall new members include beth arnholt mba ’ vice president of integrated talent management at comcast corporation mary caraccioli pdf add to briefcase file is in briefcase oct   agile therapeutics commercial head presents at th annual digital pharma east  working with patient advocacy groups to develop an integrated unbranded education and adherence program experience in contraception in young women may   data on agile therapeutics lowdose contraceptive patch ag presented at american college of obstetricians and gynecologists acog annual clinical meeting pdf add to briefcase file is in briefcase may   data on agile therapeutics lowdose contraceptive patch ag presented at the first global conference on contraception reproduction and sexual health organized by the european society of contraception and reproductive health escrh pdf add to briefcase file is in briefcase feb   agile therapeutics president and ceo appointed to board of bionj pdf add to briefcase file is in briefcase feb   agile therapeutics chief medical officer marie foegh md named one of new jerseys best  women in business by njbiz pdf add to briefcase file is in briefcase jan   agile therapeutics closes  million financing agreement with oxford finance pdf add to briefcase file is in briefcase nov   agile therapeutics to present at elsevier business intelligences therapeutic area partnerships pdf add to briefcase file is in briefcase nov   agile therapeutics commercial head named bronze stevie winner in the  stevie® awards for women in business pdf add to briefcase file is in briefcase nov   phase iii data show greater compliance across demographic groups with agile therapeutics contraceptive patch compared to an oral contraceptive pdf add to briefcase file is in briefcase oct   agile therapeutics commercial head to present at digital pharma east pdf add to briefcase file is in briefcase sep   phase iii data show agile therapeutics’ contraceptive patch had greater compliance than an oral contraceptive pdf add to briefcase file is in briefcase sep   agile therapeutics to present at cbi’s forum on phase iiiii clinical study optimization pdf add to briefcase file is in briefcase aug   agile therapeutics announces three new us patents on its technology and the brand name twirla™ for its first contraceptive patch pdf add to briefcase file is in briefcase aug   agile therapeutics chief medical officer dr marie foegh selected as one of top  healthcare leaders by pharmavoice pdf add to briefcase file is in briefcase jul   agile therapeutics to present at onemedforum new york  pdf add to briefcase file is in briefcase jul   agile therapeutics announces fda accepts new drug application for its lowdose onceweekly contraceptive patch pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the th european society of contraception and reproductive health congress pdf add to briefcase file is in briefcase jun   agile therapeutics to present at biotechnology industry organization international convention pdf add to briefcase file is in briefcase jun   agile therapeutics cfo scott coiante named finalist for new jersey technology council’s  cfo of the year pdf add to briefcase file is in briefcase may   agile therapeutics president and chief executive officer al altomari is an ernst  young entrepreneur of the year®  finalist in new jersey pdf add to briefcase file is in briefcase may   new phase iii data show agile therapeutics’ lowdose patch is comparable to combination oral contraceptive in a comparator study pdf add to briefcase file is in briefcase may   agile therapeutics named finalist for pact  pdf add to briefcase file is in briefcase apr   new studies on agile therapeutics’ lowdose contraceptive patch to be presented at the american college of obstetricians and gynecologists’ annual clinical meeting pdf add to briefcase file is in briefcase mar   agile ceo presents at needham healthcare conference pdf add to briefcase file is in briefcase mar   agile therapeutics to speak at late phase drug development world americas  pdf add to briefcase file is in briefcase jan   agile therapeutics raises  million in a series c financing pdf add to briefcase file is in briefcase jan   agile therapeutics announces completion of ag phase iii clinical program pdf add to briefcase file is in briefcase  add release to briefcase legal     terms and conditions      sitemap      home     contact press releases  agile therapeutics our company overview of agile management team board of directors key advisorsconsultants scientific advisory board product pipeline technology twirla ag other product candidates investor relations press releases events  presentations corporate governance financials  filings stock information investor faqs contact us contact us investor relations overview press releases events  presentations corporate governance management board of directors committee composition financials  filings sec filings stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools shareholder briefcase email alerts snapshot rss news feeds press releases   year all years         sort by date descending date ascending update   press releases date title and summary view jun   agile therapeutics resubmits new drug application nda for its transdermal contraceptive patch twirla® princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced it has resubmitted to the us food and drug administration fda the nda for its lead product candidate twirla® an investigational lowdose combined hormonal contraceptiv pdf add to briefcase file is in briefcase may   agile therapeutics reports first quarter  financial results princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today reported financial results for the three months ended march   and provided a corporate update for the first quarter  first quarter  and other recent corp pdf add to briefcase file is in briefcase may   agile therapeutics reports additional phase  secure study results relating to twirla® at acog  princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced the presentation of additional results of its phase  secure trial of its investigational lowdose combination hormone contraceptive patch twirla® ag anita nelson md profess pdf add to briefcase file is in briefcase may   agile therapeutics to present additional phase  data at the  annual clinical and scientific meeting of the american congress of obstetricians and gynecologists princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced that data from its phase  secure study will be presented at the interactive eposter session during the  annual clinical and scientific meeting of the american congress of obstetricians a pdf add to briefcase file is in briefcase apr   agile therapeutics announces presentation of secure phase  data at the  congress on womens health princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company announced today that a presentation entitled an update on hormonal contraception and the changing us population will be presented by coprincipal investigator of the secure clinical trial anit pdf add to briefcase file is in briefcase apr   agile therapeutics announces results of its presubmission meeting with fda princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company today announced it has received the final meeting minutes from its recent new drug application nda presubmission meeting with the us food and drug administration fda for its lead product candidate  pdf add to briefcase file is in briefcase mar   agile therapeutics announces a poster presentation of its secure phase  study at the contraceptive technology  conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens healthcare company announced a poster presentation of data from the secure phase  clinical trial for its lead product candidate twirla® ethinyl estradiol and levonorgestrel transdermal system also known pdf add to briefcase file is in briefcase mar   agile therapeutics reports fourth quarter and full year  financial results princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company today reported financial results for the three months and year ended december   and provided a corporate update for the fourth quarter   pdf add to briefcase file is in briefcase mar   agile therapeutics to present at th annual roth conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at th annual roth conference on monday march   at  pm pacific time the conference is being held  pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the rbc capital markets  global healthcare conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at the rbc capital markets  global healthcare conference on february   at  am et at the new york palace in new  pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  bio ceo  investor conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at the  bio ceo  investor conference on monday february   at  am et at the waldorf astoria in pdf add to briefcase file is in briefcase jan   agile therapeutics to present at noble capital markets thirteenth annual investorequity conference princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at noble capital markets thirteenth annual investor equity conference on tuesday january   at  am e pdf add to briefcase file is in briefcase jan   agile therapeutics announces positive topline phase  results resubmission of twirla® new drug application expected to address fdas complete response lettercompany plans to resubmit nda in first half of             company to host conference call on january   at  pm pdf add to briefcase file is in briefcase dec   agile therapeutics to present at biotech showcase  princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx announced today that its chief executive officer al altomari will present at the biotech showcase  on monday january   at  am pacific time   the conference will be held at the hilton san francisco union square pdf add to briefcase file is in briefcase dec   agile therapeutics to present at the th annual jp morgan healthcare conference princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that its chief executive officer al altomari will present at the th annual jp morgan healthcare conference on thursday january   at  am pacific time  pdf add to briefcase file is in briefcase dec   agile therapeutics receives approximately  million in nondilutive funding from new jerseys technology business tax certificate transfer program princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company announced today that it has received net proceeds of approximately  million in nondilutive financing through the state of new jerseys technology business tax certificate transfer pro pdf add to briefcase file is in briefcase nov   agile therapeutics reports third quarter  financial results and announces completion of subject visits for twirla® phase  secure clinical trial topline data expected in early january  resubmission planned for first half   cash expected to fund operations through the end of  princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a wom pdf add to briefcase file is in briefcase aug   agile therapeutics reports second quarter  financial results princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and six months ended june   and provide pdf add to briefcase file is in briefcase jul   agile therapeutics appoints seth h z fischer to its board of directors princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx today announced the appointment of seth h z fischer to the companys board of directors effective july    mr fischer will serve on agiles compensation and nominating  corporate governance committees  pdf add to briefcase file is in briefcase jul   agile therapeutics announces plans to advance contraceptive pipeline princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that preparations are underway for an initial phase  clinical trial of a novel  pdf add to briefcase file is in briefcase jul   agile therapeutics strengthens executive leadership team with new chief commercial officer princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that it had strengthened its executive leadership team with the appointment  pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the cantor fitzgeralds nd annual healthcare conference princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase jun   agile therapeutics announces issuance of patent for progestin patch designs princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued us patent  on june pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the william blair  companys th annual growth stock conference princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the jefferies  healthcare conference princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase may   agile therapeutics reports first quarter  financial results cash expected to fund operations through the end of clinical trial expected to complete in fourth quarter  and resubmission planned for first half  princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens heal pdf add to briefcase file is in briefcase apr   agile therapeutics to present at womens health  the th annual congress princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that dr elizabeth garner chief medical officer will present on the topic of subject recruitment f pdf add to briefcase file is in briefcase mar   agile therapeutics to present at the th annual needham healthcare conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that  pdf add to briefcase file is in briefcase mar   agile therapeutics reports fourth quarter and full year  financial results princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three months and year ended december   and provided a corpor pdf add to briefcase file is in briefcase mar   agile therapeutics to present at the th annual roth conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the t pdf add to briefcase file is in briefcase feb   agile therapeutics appoints ajit s shetty phd to its board of directors princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx today announced that ajit s shetty phd has been appointed to the companys board of directors effective february    dr shetty will serve on agiles science  technology and nominating  governance committees  pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  rbc capital markets global healthcare conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the  pdf add to briefcase file is in briefcase feb   agile therapeutics inc announces full exercise of option to purchase additional shares by underwriters princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the underwriters of its previously announced public offering of common  pdf add to briefcase file is in briefcase jan   agile therapeutics announces pricing of its public offering of common stock princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced the pricing of its underwritten public offering of  shares of its c pdf add to briefcase file is in briefcase jan   agile therapeutics announces proposed offering of common stock princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that it intends to offer and sell  million of shares of its common stock sub pdf add to briefcase file is in briefcase jan   agile therapeutics to present at noble financial capital markets twelfth annual equity conference princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that katie macfarlane chief commercial officer will present at noble financial  pdf add to briefcase file is in briefcase dec   agile therapeutics receives approximately  million in nondilutive funding from new jerseys technology business tax certificate transfer program princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that it has received net proceeds of approximately  million in nondilutive financing through pdf add to briefcase file is in briefcase nov   agile therapeutics announces participation at upcoming investor conferences princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari president and chief executive officer will participate in  pdf add to briefcase file is in briefcase nov   agile therapeutics reports third quarter financial results princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and nine months ended september   and prov pdf add to briefcase file is in briefcase oct   agile therapeutics announces completion of patient enrollment in twirlar phase  secure clinical trial princeton nj oct   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that it has reached full enrollment in its ongoing phase  secure clinical tria pdf add to briefcase file is in briefcase sep   agile therapeutics to participate at fbr second annual healthcare conference princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari president and chief executive officer will participate at the fbr second annual h pdf add to briefcase file is in briefcase aug   agile therapeutics announces completion of patient recruitment in twirlar phase  secure clinical trial princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that active recruitment has closed in its ongoing singlearm openlabel phase  secure clinical tria pdf add to briefcase file is in briefcase aug   agile therapeutics announces presentation at upcoming conferences princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that management will present at the following conferences al altomari president and c pdf add to briefcase file is in briefcase aug   agile therapeutics reports second quarter financial results princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and six months ended june   and provided a corporate update fo pdf add to briefcase file is in briefcase jul   agile therapeutics announces allowance of several patents on novel dosing regimens for its pipeline of followon contraceptive products princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued notices of allowance between july  and  for fo pdf add to briefcase file is in briefcase jul   agile therapeutics to present at the cantor fitzgerald inaugural healthcare conference princeton nj july   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the cantor fitzgerald inaugura pdf add to briefcase file is in briefcase jun   agile therapeutics added to membership of russell r r and global indexes princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that its stock has been selected for addition to the us russell ® russell ® and  pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the jmp securities life sciences conference  princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the jmp securities life scien pdf add to briefcase file is in briefcase jun   agile therapeutics announces issuance of patent for twirlar patch design princeton nj june   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued us patent  on june   the newlyiss pdf add to briefcase file is in briefcase may   agile therapeutics to present at the william blair th annual growth stock conference princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the william blair th annual  pdf add to briefcase file is in briefcase may   agile therapeutics reports first quarter financial results princeton nj may   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the quarter ended march  first quarter  corporate developments inclu pdf add to briefcase file is in briefcase apr   agile therapeutics to present at the th annual needham healthcare conference princeton nj april   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the th annual needham healt pdf add to briefcase file is in briefcase mar   agile therapeutics reports fourth quarter and full year  financial results princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the fourth quarter and year ended december  fourth quarter  and ot pdf add to briefcase file is in briefcase mar   agile therapeutics to present at the th annual roth conference princeton nj march   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the th annual roth conferen pdf add to briefcase file is in briefcase feb   agile therapeutics secures debt facility from hercules technology growth capital of up to  million and provides update on status of clinical trial princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that it has entered into a loan and security agreement with hercules technology growth capital inc pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  rbc capital markets global healthcare conference princeton nj feb   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the  rbc capital markets pdf add to briefcase file is in briefcase jan   agile therapeutics announces  million private placement and provides clinical trial update princeton new jersey jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that it has entered into a definitive stock purchase agreement with a group of institutional a pdf add to briefcase file is in briefcase jan   agile therapeutics to present at noble financial capital markets eleventh annual equity conference princeton nj jan   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the noble financial capital ma pdf add to briefcase file is in briefcase dec   agile therapeutics to present at the rd annual jp morgan healthcare conference princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that al altomari president and chief executive officer will present at the rd annual jp morgan  pdf add to briefcase file is in briefcase dec   agile therapeutics announces publication of data on lowdose investigational contraceptive patch princeton nj dec   globe newswire  agile therapeutics inc nasdaqagrx today announced the publication of two manuscripts containing data from a phase  clinical trial of twirla® ag an investigational onceweekly contraceptive patch kaunitz a portman d westhoff c mishell d archer d foegh m new contracepti pdf add to briefcase file is in briefcase nov   agile therapeutics appoints john hubbard phd fcp to its board of directors princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx today announced that john hubbard phd fcp has been appointed to the companys board of directors effective november   dr hubbard will serve on agiles nominating and corporate governance committee johns exceptional pharmaceutical experien pdf add to briefcase file is in briefcase nov   agile therapeutics reports third quarter  financial results princeton nj nov   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and nine months ended september   and provided a company upda pdf add to briefcase file is in briefcase oct   agile therapeutics appoints james p tursi md to its board of directors princeton nj oct   globe newswire  agile therapeutics inc nasdaqagrx announced today that james p tursi md has been appointed to the companys board of directors effective october   dr tursi will serve on the compensation committee james has significant clinical and regulatory expertise in the pharmaceutical i pdf add to briefcase file is in briefcase sep   agile announces dosing of first patients in twirlar phase  secure study princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the first patients have been dosed in its secure study the secure study is a singlearm open pdf add to briefcase file is in briefcase sep   agile to present at the st annual biocentury newsmakers conference princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari president and chief executive officer will present a business overview and updat pdf add to briefcase file is in briefcase sep   agile initiates phase  secure study for twirlatm twirla ag is a novel lowdose combined hormonal contraceptive patch designed using the companys proprietary transdermal skinfusion® technologyconfirmatory secure study to build upon data from previous phase  studies in support of the companys new drug application to the us food and drug administration princeton nj sept  pdf add to briefcase file is in briefcase sep   agile therapeutics to ring the nasdaq stock market closing bell princeton nj sept   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that mr al altomari the companys president and chief executive officer will ring the nasdaq stock pdf add to briefcase file is in briefcase aug   agile therapeutics reports second quarter  financial results princeton nj aug   globe newswire  agile therapeutics inc nasdaqagrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today reported financial results for the three and six months ended june   and provided a company update on  pdf add to briefcase file is in briefcase jul   agile therapeutics announces allowance of additional patent claims for skinfusion® princeton nj july   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that the us patent and trademark office issued a notice of allowance on july   for additional pdf add to briefcase file is in briefcase jun   agile therapeutics joins russell microcap® index princeton nj june   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced it has been added to the russell microcap index the company joined the index at the close of the mark pdf add to briefcase file is in briefcase jun   agile therapeutics announces issuance of new patent for its skinfusion® transdermal delivery device princeton nj june   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that patent us   patent was issued by the us patent and trademark office on june  pdf add to briefcase file is in briefcase jun   agile therapeutics to participate at the janney capital markets boston healthcare x corporate access day princeton nj june   prnewswire  agile therapeutics inc nasdaq agrx a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced that al altomari the companys chief executive officer and president will participate at the janney  pdf add to briefcase file is in briefcase may   agile therapeutics announces pricing of initial public offering princeton nj may   prnewswire  agile therapeutics inc a womens health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products today announced the pricing of its initial public offering of  shares of its common stock at a public offering price of   pdf add to briefcase file is in briefcase mar   agile therapeutics files registration statement for proposed initial public offering pdf add to briefcase file is in briefcase feb   agile therapeutics announces appointment of science advisory board member pdf add to briefcase file is in briefcase feb   agile therapeutics to present at the  leerink global healthcare conference pdf add to briefcase file is in briefcase jan   agile therapeutics appoints dr elizabeth ijeoma onyemelukwe garner as chief medical officer pdf add to briefcase file is in briefcase oct   agile president and ceo appointed as an officer of the deans advisory board drexel university lebow college of business the dean’s advisory board elected five new members and three new officers at its fall meeting – its first held in gerri c lebow hall new members include beth arnholt mba ’ vice president of integrated talent management at comcast corporation mary caraccioli pdf add to briefcase file is in briefcase oct   agile therapeutics commercial head presents at th annual digital pharma east  working with patient advocacy groups to develop an integrated unbranded education and adherence program experience in contraception in young women may   data on agile therapeutics lowdose contraceptive patch ag presented at american college of obstetricians and gynecologists acog annual clinical meeting pdf add to briefcase file is in briefcase may   data on agile therapeutics lowdose contraceptive patch ag presented at the first global conference on contraception reproduction and sexual health organized by the european society of contraception and reproductive health escrh pdf add to briefcase file is in briefcase feb   agile therapeutics president and ceo appointed to board of bionj pdf add to briefcase file is in briefcase feb   agile therapeutics chief medical officer marie foegh md named one of new jerseys best  women in business by njbiz pdf add to briefcase file is in briefcase jan   agile therapeutics closes  million financing agreement with oxford finance pdf add to briefcase file is in briefcase nov   agile therapeutics to present at elsevier business intelligences therapeutic area partnerships pdf add to briefcase file is in briefcase nov   agile therapeutics commercial head named bronze stevie winner in the  stevie® awards for women in business pdf add to briefcase file is in briefcase nov   phase iii data show greater compliance across demographic groups with agile therapeutics contraceptive patch compared to an oral contraceptive pdf add to briefcase file is in briefcase oct   agile therapeutics commercial head to present at digital pharma east pdf add to briefcase file is in briefcase sep   phase iii data show agile therapeutics’ contraceptive patch had greater compliance than an oral contraceptive pdf add to briefcase file is in briefcase sep   agile therapeutics to present at cbi’s forum on phase iiiii clinical study optimization pdf add to briefcase file is in briefcase aug   agile therapeutics announces three new us patents on its technology and the brand name twirla™ for its first contraceptive patch pdf add to briefcase file is in briefcase aug   agile therapeutics chief medical officer dr marie foegh selected as one of top  healthcare leaders by pharmavoice pdf add to briefcase file is in briefcase jul   agile therapeutics to present at onemedforum new york  pdf add to briefcase file is in briefcase jul   agile therapeutics announces fda accepts new drug application for its lowdose onceweekly contraceptive patch pdf add to briefcase file is in briefcase jun   agile therapeutics to present at the th european society of contraception and reproductive health congress pdf add to briefcase file is in briefcase jun   agile therapeutics to present at biotechnology industry organization international convention pdf add to briefcase file is in briefcase jun   agile therapeutics cfo scott coiante named finalist for new jersey technology council’s  cfo of the year pdf add to briefcase file is in briefcase may   agile therapeutics president and chief executive officer al altomari is an ernst  young entrepreneur of the year®  finalist in new jersey pdf add to briefcase file is in briefcase may   new phase iii data show agile therapeutics’ lowdose patch is comparable to combination oral contraceptive in a comparator study pdf add to briefcase file is in briefcase may   agile therapeutics named finalist for pact  pdf add to briefcase file is in briefcase apr   new studies on agile therapeutics’ lowdose contraceptive patch to be presented at the american college of obstetricians and gynecologists’ annual clinical meeting pdf add to briefcase file is in briefcase mar   agile ceo presents at needham healthcare conference pdf add to briefcase file is in briefcase mar   agile therapeutics to speak at late phase drug development world americas  pdf add to briefcase file is in briefcase jan   agile therapeutics raises  million in a series c financing pdf add to briefcase file is in briefcase jan   agile therapeutics announces completion of ag phase iii clinical program pdf add to briefcase file is in briefcase  add release to briefcase legal     terms and conditions      sitemap      home     contact agile therapeutics inc nasdaqagrx agile therapeutics inc agrx product news news  stocknewscom     follow us stocktwits twitter agile therapeutics inc agrx product news news agrx – company resubmitted to the fda the nda for its lead product candidate twirla an investigational lowdose combined hormonal contraceptive patch jun    am  by stocknewscom staff product news key facts surrounding this news item agrx had a powr rating of d sell coming into today agrx was  below its day moving average coming into today agrx was  above its day moving average coming into today agrx was  above its day moving average coming into today agrx was  above its day moving average coming into today agrx was  below its day moving average coming into today agrx had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about agile therapeutics inc agrx agile therapeutics inc focuses on the development and commercialization of prescription contraceptive products for women the company was founded in  and is based in princeton new jersey view our full agrx ticker page with ratings news and more agrx at a glance agrx current powr rating™ overall powr rating™ agrx current price   more agrx ratings data and news agrx price reaction the day of this event jun  agrx closing price agrx volume from avgleading up to this eventagrx mo returnnaafter this eventagrx day returnagrx day returnagrx day return agrx price chart more agile therapeutics inc agrx news view all eventdate symbol news detail start price end price change powr rating loading please wait view all agrx news page generated in  seconds management  agile therapeutics our company overview of agile management team board of directors key advisorsconsultants scientific advisory board product pipeline technology twirla ag other product candidates investor relations press releases events  presentations corporate governance financials  filings stock information investor faqs contact us contact us investor relations overview press releases events  presentations corporate governance management board of directors committee composition financials  filings sec filings stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools shareholder briefcase email alerts snapshot rss news feeds management show all alfred altomari chairman of the board chief executive officer mr alfred altomari serves as our chairman of the board and chief executive officer since october  and has been a member of our board of directors since february  mr altomari served as president and chief executive officer from  to  previously mr altomari served as agiles executive chairman from  to  from  to september  mr altomari was also a consultant to agile from  to  mr altomari held multiple senior management positions at barrier therapeutics inc including chief commercial officer chief operating officer and chief executive officer in  in his role as chief executive officer and as a member of barriers board of directors mr altomari completed the successful sale of barrier to stiefel laboratories which was subsequently acquired by glaxosmithkline plc from  to  mr altomari held numerous executive roles in general management commercial operations business development product launch preparation and finance with johnson  johnson mr altomari also serves on the board of directors of insmed inc and recro pharma inc mr altomari received an mba from rider university and his bs from drexel university he currently serves on lebow college of business advisory board and the board of the charles d close school of entrepreneurship at drexel university he currently is a member of the board of directors for task trenton area soup kitchen scott m coiante senior vice president and chief financial officer mr scott coiante has served as our senior vice president and chief financial officer since june  he joined us in december  and served as our vice president of finance between then and june  beginning in  he served as vice president finance treasurer principal accounting officer at medarex inc a publicly listed biopharmaceutical company which bristolmyers squibb co acquired in september  and during  through  he served as director of finance while at medarex he was responsible for corporate financial functions including treasury accounting sec reporting tax and assurance from  to  he held management positions of increasing responsibilities at ernst  young llp which included managing audit engagements financial preparation and financial reporting for client public offerings both initial and followon and sec registration filing statements for both public and private companies predominantly within the life science and pharmaceutical industries he holds a bs in accounting from villanova university elizabeth garner md mph senior vice president and chief medical officer dr elizabeth garner has served as our senior vice president and chief medical officer since january  previously she served as vice president medical affairs womens health and preventive care at myriad genetics laboratories from  to  from  to  she was senior medical director womens health at abbott laboratories where she served as the clinical lead endometriosis program prior to that dr garner served as associate director and then director vaccines clinical research at merck research laboratories from  to  dr garner received joint md and mph degrees from harvard medical school and the school of public health she completed her residency in obstetrics and gynecology at brigham and womensmassachusetts general hospitals her subspecialty fellowship in gynecologic oncology at brigham and womens and the danafarber cancer institute and received board certification in both general obstetrics and gynecology and gynecologic oncology prior to entering the pharmaceutical industry she had several years of experience in academic clinical practice research and teaching at harvard medical school geoffrey p gilmore general counsel mr geoffrey gilmore has served as our legal advisor since april  and became our general counsel in august  mr gilmore was a principal of life sciences advisory services which provides business legal and compliance consulting services to the pharmaceutical and life science industries from  to april  he served as senior vice president general counsel and corporate secretary of amicus therapeutics inc a nasdaqlisted biopharmaceutical company from  to  prior to joining amicus mr gilmore spent ten years at bristolmyers squibb where he held various roles in the legal department with the commercial intellectual property and rd legal groups and served in the office of the corporate secretary and as vicepresident and senior counsel corporate securities mr gilmore began his legal career in the business and finance groups at philadelphiabased law firms ballard spahr llc and montgomery mccracken walker  rhoads llp mr gilmore received his ba degree from franklin and marshall college and his jd from the university of michigan law school renee selman chief commercial officer ms selman has served as our chief commercial officer since july  previously from  to  ms selman served as the president of adheris health which is one of the nations largest providers of targeted patient education and adherence programs delivered through the pharmacy channel from  ms selman served as president of catalina health a division of catalina marketing leading the day to day operations and strategy development she led the strategic transition of catalina health which was divested by catalina acquired by inventiv and merged with adheris prior to catalina health ms selman spent  years at johnson  johnson or jj where she held senior executive roles including worldwide president ethicon womens health and urology from  to  and vice president us sales and marketing wound management from  to  while at jj she held roles of increasing responsibility at orthomcneil pharmaceutical including group director ortho evra® from  to  where she led a crossfunctional team that launched the first ever contraceptive patch ms selman serves on the boards of the hunterdon county medical center and orthogenrx inc she is a graduate of purdue university with a bsim legal     terms and conditions      sitemap      home     contact agrx key statistics  agile therapeutics inc financial ratios  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close agile therapeutics inc nasdaq agrx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus agile therapeutics inc after hours  quotes are delayed by  min jul    pm agrx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description agile therapeutics inc engages in the development and commercialization of new prescription contraceptive products its product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance the company was founded on december   agile therapeutics inc engages in the development and commercialization of new prescription contraceptive products its product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance the company was founded on december   and is headquartered in princeton nj valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  total debt to enterprise value  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title mr alfred f altomari   president chief executive officer  director mr scott m coiante   chief financial officer  vice president dr elizabeth ijeoma onyemelukwe garner   chief medical officer  senior vice president ms renee selman   chief commercial officer mr seth h z fischer   director insider actions – purchase – sale  – number of transactions  date name shares transaction value  ajit s shetty director    derivativenonderivative trans at  per share   alfred f altomari chairman and chief executive o director    acquisition at  per share   renee selman chief commercial officer    acquisition at  per share   alfred f altomari chairman and chief executive o director    derivativenonderivative trans at  per share   alfred f altomari chairman and chief executive o director    derivativenonderivative trans at  per share   alfred f altomari chairman and chief executive o director    derivativenonderivative trans at  per share   alfred f altomari chairman and chief executive o director    acquisition at  per share   alfred f altomari chairman and chief executive o director    derivativenonderivative trans at  per share   aisling capital llc    acquisition at  per share   alfred f altomari chairman and chief executive o director    derivativenonderivative trans at  per share   investor ab investment company    acquisition at  per share   care capital llc    acquisition at  per share   care capital llc    derivativenonderivative trans at  per share   care capital llc    derivativenonderivative trans at  per share   care capital llc    derivativenonderivative trans at  per share  newslatestcompanyusagrx marketwatch news on agrx stock market ends near records powered by auto sales  pm jan    wallace witkowski agile therapeutics stock price target cut to  vs  at rbc  am jan    ciara linnane agile therapeutics shares plummet after contraceptive study data  pm jan    wallace witkowski newsnonmarketwatchcompanyusagrx other news on agrx  things in biotech you should learn today june    am june    seeking alpha agile resubmits nda for contraceptive patch twirla shares up   pm june    seeking alpha agile therapeutics no reason for the fda to approve another inferior patch  am may    seeking alpha q agile therapeutics inc  pm may    edgar online  edg  q k agile therapeutics announces results of its presubmission meeting with fda  am april    seeking alpha agile therapeutics agrx catches eye stock moves up   am march    zackscom k agile therapeutics inc  pm march    edgar online  edg  q k wellcare health plans prices senior notes worth  billion  am march    zackscom agile therapeutics agrx investor presentation  slideshow  am jan    seeking alpha agile therapeutics is oversold due to misunderstood clinical trial results  pm jan    seeking alpha clinical development news jan   pm jan    the wall street journal interactive edition agile therapeutics agrx presents topline phase  results for twirla  am jan    seeking alpha biotech forum daily digest biotech starts  with big rally spotlight on ultragenyx pharmaceuticals  pm jan    seeking alpha  stocks to watch on wednesday tesla motors inc tsla agile therapeutics inc agrx and regeneron pharmaceuticals inc regn  am jan    investorplacecom agiles positive latestage trial data for contraceptive patch twirla aint so positive shares plummet  after hours  pm jan    seeking alpha biggest movers in manufacturing stocks now – catb xrm airi cemp  pm jan    investorplacecom agile therapeutics nabs m in funding from nj biotech development program  am dec    seeking alpha  pharmaceuticals stocks to sell now  am nov    investorplacecom  pharmaceuticals stocks to sell now  am nov    investorplacecom biggest movers in manufacturing stocks now – scmp ebio rvnc agtc  pm nov    investorplacecom loading more headlines at a glance agile therapeutics inc  poor farm road princeton new jersey  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for agrx newspressreleasecompanyusagrx press releases on agrx agile therapeutics resubmits new drug application nda for its transdermal contraceptive patch twirlar  am june    globenewswire agile therapeutics reports additional phase  secure study results relating to twirlar at acog   pm may    globenewswire agile therapeutics to present additional phase  data at the  annual clinical and scientific meeting of the american congress of obstetricians and gynecologists  pm may    globenewswire agile therapeutics announces presentation of secure phase  data at the  congress on womens health  am april    globenewswire agile therapeutics announces results of its presubmission meeting with fda  am april    globenewswire generic drugs stocks on investors radar  diplomat pharma momenta pharma agile therapeutics and sophiris bio  am april    pr newswire  prf agile therapeutics announces a poster presentation of its secure phase  study at the contraceptive technology  conference  pm march    globenewswire agile therapeutics reports fourth quarter and full year  financial results  pm march    globenewswire important equity alert khang  khang llp announces a class action lawsuit against agile therapeutics inc and encourages investors with losses to contact the firm  pm march    accesswire deadline alert  bronstein gewirtz  grossman llc reminds investors of class action against agile therapeutics inc agrx  lead plaintiff deadline  march    am march    globenewswire shareholder alert pomerantz law firm reminds shareholders with losses on their investment in agile therapeutics inc of class action lawsuit and upcoming deadline  agrx  pm march    globenewswire shareholder alert lundin law pc announces securities class action lawsuit against agile therapeutics inc and encourages investors with losses to contact the firm  am march    accesswire upcoming deadline levi  korsinsky llp reminds shareholders of agile therapeutics inc of commencement of a class action lawsuit and a lead plaintiff deadline of march    am march    businesswire  bzx equity alert rosen law firm announces filing of securities class action lawsuit against agile therapeutics inc  agrx  pm march    pr newswire  prf how these generic drugs stocks are faring  diplomat pharmacy momenta pharma agile therapeutics and sophiris bio  am march    pr newswire  prf agile therapeutics to present at th annual roth conference  pm march    globenewswire deadline alert  bronstein gewirtz  grossman llc reminds investors of class action against agile therapeutics inc agrx and lead plaintiff deadline  march    am march    accesswire deadline alert brower piven reminds investors of the march   deadline in class action lawsuit and encourages investors with losses in excess of  from investment in agile therapeutics inc to contact the firm  pm feb    businesswire  bzx shareholder alert faruqi  faruqi llp encourages investors who suffered losses in excess of  investing in agile therapeutics inc to contact the firm before imminent lead plaintiff deadline  pm feb    accesswire important shareholder alert khang  khang llp announces a class action lawsuit against agile therapeutics inc and encourages investors with losses to contact the firm  am feb    accesswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  agile therapeutics inc  agrx  stock price today  zacks agrx is down  today but wheres it headed in august privacy policy no cost no obligation to buy anything ever join sign in member sign in keep me signed in what does remember me do forgot password create a new account you are being directed to zackstrade a division of lbmz securities and licensed brokerdealer zackstrade and zackscom are separate companies the web link between the two companies is not a solicitation or offer to invest in a particular security or type of security zackstrade does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating indiv idual securities if you wish to go to zackstrade click ok if you do not click cancel ok cancel back to top more agile therapeutics inc agrx delayed data from nsdq  usd     updated jul    pm et add to portfolio zacks rank style scores na value  na growth  na momentum  na vgm the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores industry rank bottom  out of  industry medical  generic drugs view all zacks  ranked stocks trades from  this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn about the zacks rank zacks rank home  zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank quote overview stock activity open  day low  day high   wk low   wk high  avg volume  market cap  m dividend    beta  key earnings data earnings esp  most accurate est  current qtr est  current yr est  exp earnings date  prior year eps  exp eps growth yrna forward pe na peg ratio na medical » medical  generic drugs zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings news for agrx zacks news for agrx other news for agrx agile therapeutics agrx catches eye stock moves up  am est zacks wellcare health plans prices senior notes worth  billion am est zacks agrx what are zacks experts saying now zacks private portfolio services more zacks news for agrx healthcare  top  gainers  losers as of  am est seeking alpha midday gainers  losers pm est seeking alpha healthcare  top  gainers  losers as of  am am est seeking alpha premarket analyst action  healthcare am est seeking alpha  things in biotech you should learn today june   am est seeking alpha more other news for agrx premium research for agrx zacks rank na zacks industry rank bottom  out of  zacks sector rank bottom   out of  style scores na value  na growth  na momentum  na vgm earnings esp  research report for agrx snapshot this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to get access to the zacks rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the three scores are based on the trading styles of growth value and momentum growth score a value score a momentum score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b zacks style scores education  learn more about the zacks style scores the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports   change in last  days view all zacks rank  strong buys premium research industry analysis top peers symbol zacks rank agile therapeutics inc agrx na aspen pharmacr apnhy acura pharmaceuticals inc acur adamas pharmaceuticals inc adms akorn inc akrx allergan plc agn amphastar pharmaceuticals inc amph see all medical  generic drugs peers price and eps surprise chart  month  months ytd interactive chart  fundmental chart billion dollar secret company summary agile therapeutics inc is a womens health specialty pharmaceutical company it is focused on the development and commercialization of new prescription contraceptive products the companys lead product candidate is twirla tm also known as ag a onceweekly prescription contraceptive patch currently in phase  clinical development agile therapeutics inc is headquartered in princeton new jersey agile therapeutics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports agile therapeutics inc  product pipeline review   agile therapeutics inc  product pipeline review   wgr  march  global  pages global markets direct description table of content sample report enquiry before buy related reports agile therapeutics inc  product pipeline review  summaryglobal markets direct’s ‘agile therapeutics inc  product pipeline review  ’ provides an overview of the agile therapeutics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of agile therapeutics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of agile therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of agile therapeutics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the agile therapeutics inc’s pipeline productsreasons to buy evaluate agile therapeutics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of agile therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the agile therapeutics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of agile therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of agile therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of agile therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures agile therapeutics inc snapshot agile therapeutics inc overview key information key facts agile therapeutics inc  research and development overview key therapeutic areas agile therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities agile therapeutics inc  pipeline products glance agile therapeutics inc  late stage pipeline products phase iii productscombination treatment modalities agile therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities agile therapeutics inc  early stage pipeline products discovery productscombination treatment modalities agile therapeutics inc  drug profiles ethinyl estradiol  levonorgestrel product description mechanism of action rd progress ag er product description mechanism of action rd progress levonorgestrel product description mechanism of action rd progress ag sp product description mechanism of action rd progress agile therapeutics inc  pipeline analysis agile therapeutics inc  pipeline products by target agile therapeutics inc  pipeline products by route of administration agile therapeutics inc  pipeline products by molecule type agile therapeutics inc  pipeline products by mechanism of action agile therapeutics inc  recent pipeline updates agile therapeutics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesagile therapeutics inc key information agile therapeutics inc key facts agile therapeutics inc  pipeline by indication  agile therapeutics inc  pipeline by stage of development  agile therapeutics inc  monotherapy products in pipeline  agile therapeutics inc  combination treatment modalities in pipeline  agile therapeutics inc  phase iii  agile therapeutics inc  phase ii  agile therapeutics inc  phase i  agile therapeutics inc  discovery  agile therapeutics inc  pipeline by target  agile therapeutics inc  pipeline by route of administration  agile therapeutics inc  pipeline by molecule type  agile therapeutics inc  pipeline products by mechanism of action  agile therapeutics inc  recent pipeline updates  list of figuresagile therapeutics inc  pipeline by stage of development  agile therapeutics inc  monotherapy products in pipeline  agile therapeutics inc  pipeline by top  target  agile therapeutics inc  pipeline by top  route of administration  agile therapeutics inc  pipeline by top  molecule type  agile therapeutics inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send agile therapeutics c our company overview of agile management team board of directors key advisorsconsultants scientific advisory board product pipeline technology twirla ag other product candidates investor relations press releases events  presentations corporate governance financials  filings stock information investor faqs contact us contact us agile therapeutics is a forwardthinking womens healthcare company dedicated to fulfilling the unmet health needs of todays women our current product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill without committing to a longeracting method our lead product candidate twirla® ethinyl estradiol and levonorgestrel transdermal system also known as ag is a onceweekly prescription contraceptive patch that recently completed phase  trials twirla is based on our proprietary transdermal patch technology called skinfusion® which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability our shortterm goal is to establish a marketleading franchise in the united states hormonal contraceptive market which had total market sales of approximately  billion in  news and events legal    terms and conditions     sitemap     home    contact follow agilether bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one